Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Positive phase III trial results reported for phosphate binder

Jan. 9, 1997

P&U files for European approval of urinary incontinence Rx

Jan. 9, 1997

Watson's first NDA product approved

Jan. 3, 1997

Anti-TGF-beta MAbs from Celtrix

Dec. 31, 1996

LJP licenses rights to drug for lupus

Dec. 30, 1996

Nonsteroidal 5alpha-reductase inhibitors reported by Kyowa Hakko

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

Licensees sought for PKD1 gene and mutations

Dec. 17, 1996

More terazosin clinical data reported

Dec. 17, 1996

New diuretics reported by Pharmacia & Upjohn

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...